Cryo Cell International (CCEL) Long-Term Deferred Tax (2010 - 2026)

Cryo Cell International (CCEL) has reported Long-Term Deferred Tax for 15 consecutive years, with $23.6 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Long-Term Deferred Tax rose 13.55% year-over-year to $23.6 million; the TTM figure through May 2026 stood at $23.6 million (up 13.55% YoY), while the FY2025 annual figure was $23.6 million, up 13.55% from the prior year.
• Long-Term Deferred Tax held at $23.6 million in Q2 2026 per CCEL's latest filing, from $23.6 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $23.6 million in Q4 2025 and bottomed at $12.0 million in Q1 2022.
• Historically, Long-Term Deferred Tax has averaged $18.2 million across 5 years, with a median of $20.5 million in 2023.
• Annual changes were most pronounced in 2023 — Long-Term Deferred Tax jumped 49.12% — and 2024, when it increased 1.51%.
• Cryo Cell International's Long-Term Deferred Tax stood at $13.7 million in 2022, then soared by 49.12% to $20.5 million in 2023, then increased by 1.51% to $20.8 million in 2024, then increased by 13.55% to $23.6 million in 2025, then changed by 0.0% to $23.6 million in 2026.
• Business Quant data shows CCEL's Long-Term Deferred Tax at $23.6 million in Q2 2026, $23.6 million in Q1 2026, and $23.6 million in Q4 2025.